The prospectus, a Form 424B4 filed with the SEC on June 18, 2025 (dated June 17, 2025), disclosed per-share underwriting discounts and commissions of $1.19, implying total underwriting discounts and commissions of $28,560,000 across both the company and selling stockholder shares, and proceeds before expenses to the company of $15.81 per share, or $263,500,005 in aggregate. A closing 8-K filed June 20, 2025 confirmed the IPO was completed that day, with gross proceeds to the company of $283,333,339 from its own 16,666,667 shares before underwriting discounts and offering expenses.
The company stated it intended to use the estimated $252.0 million of net proceeds (after underwriting discounts and estimated offering expenses of approximately $11.5 million) to underwrite additional insurance policies, fund the growth of its business, and for general corporate purposes. No specific debt repayment or acquisition use was disclosed.
Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as representatives of the underwriters and joint book-running managers. Citizens JMP Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co. served as additional underwriters, with the underwriting table in the prospectus allocating 9,492,857 shares each to Barclays and Morgan Stanley, 1,671,429 shares each to Citizens JMP Securities and Keefe, Bruyette & Woods, and 1,671,428 shares to Piper Sandler.
The selling stockholders granted the underwriters a 30-day option to purchase up to an additional 3,600,000 shares to cover over-allotments, which would have brought the maximum offering size to $469,200,000. No subsequent SEC filing discloses whether this over-allotment option was exercised; that detail remains undisclosed.
Davis Polk & Wardwell LLP acted as legal counsel to Slide Insurance Holdings, Inc. and certain selling stockholders, passing on the validity of the shares. Skadden, Arps, Slate, Meagher & Flom LLP represented the underwriters.
The offering resulted in immediate dilution to new investors. The prospectus disclosed a pro forma net tangible book value of $4.84 per share as of March 31, 2025 (reflecting a stock split and automatic conversion of Series A preferred stock into 51,374,125 shares of common stock), which increased to a pro forma as adjusted net tangible book value of $6.27 per share after the offering, representing immediate dilution of $10.73 per share to new investors purchasing at the $17.00 IPO price.
Because Slide Insurance Holdings had no public trading history prior to this offering, the prospectus explicitly notes there was no pre-existing public market for its common stock, so pricing cannot be benchmarked against a prior closing price. The underwriters expected to deliver shares to purchasers on or about June 20, 2025 through the book-entry facilities of the Depository Trust Company, and the closing 8-K confirms the IPO closed on that date, approximately two days after the prospectus was filed.
The following details remain undisclosed in the materials reviewed: whether the underwriters' over-allotment option was exercised in whole or in part, the specific allocation of underwriting fees among the five syndicate members individually, any directed share program final take-up beyond the stated 5% reservation, and lock-up agreement terms beyond what is referenced in the prospectus's 'Shares Eligible for Future Sale' section (not independently reviewed in detail here).
